Intrauterine administration of prostaglandin F2alpha as an outpatient procedure for termination of early pregnancy.
D000028:Abortion, Induced; D000031:Abortion, Septic; D000287:Administration, Topical; D006063:Chorionic Gonadotropin / Q000097:blood; D003475:Curettage; D003975:Diazepam; D004341:Drug Evaluation; D004716:Endometritis / Q000139:chemically induced; D005260:Female; D005334:Fever / Q000139:chemically induced; D006801:Humans; D008614:Meperidine; D010298:Parity; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011453:Prostaglandins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011863:Radioimmunoassay; D013997:Time Factors; D014592:Uterine Hemorrhage / Q000139:chemically induced; D014599:Uterus
D006063:Chorionic Gonadotropin; D011453:Prostaglandins; D008614:Meperidine; D003975:Diazepam